drugset / Trial / NCT03750773

Gabapentin for Relief of Immediate Postoperative Pain

NCT03750773

Phase 1/2 Withdrawn Indiana University
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to use gabapentin as an additional or alternative treatment for short term pain control following cesarean delivery in order to reduce the use of opioid pain medication and improve overall pain control following surgery.

Timeline

Start
2019-07-02
Primary completion
2020-03
Completion
2020-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 600 mg Oral

Indications

No indication recorded.